Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Hypermarcas Gross Margin 2010-2025 | HYPMY

Current and historical gross margin for Hypermarcas (HYPMY) over the last 10 years. The current gross profit margin for Hypermarcas as of March 31, 2025 is %.
  
Hypermarcas Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-03-31 $1.20B $0.68B 56.49%
2024-12-31 $1.38B $0.81B 58.96%
2024-09-30 $1.50B $0.92B 61.08%
2024-06-30 $1.60B $0.99B 61.90%
2024-03-31 $1.63B $1.02B 62.47%
2023-12-31 $1.59B $1.00B 63.11%
2023-09-30 $1.62B $1.02B 63.10%
2023-06-30 $1.57B $0.99B 63.20%
2023-03-31 $1.50B $0.95B 63.32%
2022-12-31 $1.46B $0.92B 63.11%
2022-09-30 $1.35B $0.85B 63.28%
2022-06-30 $1.27B $0.81B 63.36%
2022-03-31 $1.17B $0.75B 63.74%
2021-12-31 $1.10B $0.71B 64.09%
2021-09-30 $1.02B $0.65B 63.89%
2021-06-30 $0.91B $0.58B 63.86%
2021-03-31 $0.82B $0.53B 63.83%
2020-12-31 $0.79B $0.51B 64.36%
2020-09-30 $0.81B $0.52B 63.84%
2020-06-30 $0.87B $0.56B 64.86%
2020-03-31 $0.92B $0.60B 65.65%
2019-12-31 $0.84B $0.53B 63.23%
2019-09-30 $0.84B $0.55B 65.52%
2019-06-30 $0.83B $0.55B 66.38%
2019-03-31 $0.84B $0.57B 67.66%
2018-12-31 $1.02B $0.73B 71.54%
2018-09-30 $1.06B $0.77B 73.02%
2018-06-30 $1.12B $0.83B 73.95%
2018-03-31 $1.13B $0.84B 74.45%
2017-12-31 $1.14B $0.85B 74.56%
2017-09-30 $1.11B $0.83B 74.30%
2017-06-30 $1.06B $0.79B 74.46%
2017-03-31 $1.03B $0.77B 74.73%
2016-12-31 $0.94B $0.70B 74.34%
2016-09-30 $0.39B $0.45B 115.01%
2016-06-30 $0.52B $0.49B 94.80%
2016-03-31 $0.70B $0.56B 80.09%
2015-12-31 $0.90B $0.67B 74.64%
2015-09-30 $1.72B $1.05B 61.28%
2015-06-30 $1.82B $1.11B 61.16%
2015-03-31 $1.92B $1.20B 62.77%
2014-12-31 $1.97B $1.25B 63.20%
2014-09-30 $1.96B $1.26B 64.11%
2014-06-30 $1.99B $1.30B 65.39%
2014-03-31 $1.95B $1.26B 64.51%
2013-12-31 $1.95B $1.25B 63.92%
2013-09-30 $1.98B $1.26B 63.67%
2013-06-30 $1.97B $1.24B 62.86%
2013-03-31 $1.98B $1.24B 62.78%
2012-12-31 $1.96B $1.21B 61.50%
2012-09-30 $1.78B $1.10B 61.97%
2012-06-30 $1.84B $1.10B 59.65%
2012-03-31 $1.96B $1.16B 59.41%
2011-12-31 $2.00B $1.21B 60.31%
2011-09-30 $2.21B $1.29B 58.14%
2011-06-30 $2.12B $1.27B 59.56%
2011-03-31 $1.96B $1.15B 58.55%
2010-12-31 $1.81B $1.04B 57.40%
2010-09-30 $1.65B $0.95B 57.87%
2010-06-30 $1.44B $0.83B 57.57%
2010-03-31 $1.22B $0.71B 58.38%
2009-12-31 $1.03B $0.60B 58.41%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.831B $1.380B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $71.053B 27.33
Zoetis (ZTS) United States $68.857B 24.98
Takeda Pharmaceutical (TAK) Japan $47.283B 9.65
Daiichi Sankyo, - (DSNKY) Japan $45.957B 23.55
BeOne Medicines - (ONC) Switzerland $32.895B 0.00
Sandoz Group AG (SDZNY) Switzerland $27.654B 0.00
Summit Therapeutics (SMMT) United States $18.426B 0.00
Merck (MKKGY) Germany $16.343B 10.63
Shionogi (SGIOY) Japan $14.666B 14.69
United Therapeutics (UTHR) United States $13.773B 11.92
Neurocrine Biosciences (NBIX) United States $13.700B 40.87
Orion OYJ (ORINY) Finland $11.244B 27.10
IPSEN (IPSEY) France $11.184B 0.00
Madrigal Pharmaceuticals (MDGL) United States $9.438B 0.00
Eisai (ESAIY) $9.099B 10.26
Corcept Therapeutics (CORT) United States $7.348B 61.71
Ionis Pharmaceuticals (IONS) United States $6.814B 0.00
Stevanato Group S.p.A (STVN) Italy $6.784B 40.00
Grifols, S.A (GRFS) Spain $6.738B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.436B 0.00
Soleno Therapeutics (SLNO) United States $3.597B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.940B 13.97
Crinetics Pharmaceuticals (CRNX) United States $2.863B 0.00
Procaps Group, S.A (PROCF) Luxembourg $2.799B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.756B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.471B 8.27
Centessa Pharmaceuticals (CNTA) United Kingdom $2.230B 0.00
Ocular Therapeutix (OCUL) United States $2.144B 0.00
Dyne Therapeutics (DYN) United States $1.940B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.789B 0.00
Guardian Pharmacy Services (GRDN) United States $1.631B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.594B 23.75
Ardelyx (ARDX) United States $1.492B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.444B 0.00
Harrow (HROW) United States $1.435B 0.00
ARS Pharmaceuticals (SPRY) United States $1.328B 0.00
Xeris Biopharma Holdings (XERS) United States $1.290B 0.00
Evotec AG (EVO) Germany $1.239B 0.00
Enliven Therapeutics (ELVN) United States $1.225B 0.00
Collegium Pharmaceutical (COLL) United States $1.222B 6.68
Cronos Group (CRON) Canada $0.981B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.843B 0.00
Akebia Therapeutics (AKBA) United States $0.798B 0.00
ProKidney (PROK) United States $0.733B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.713B 7.34
Theravance Biopharma (TBPH) United States $0.695B 57.50
KalVista Pharmaceuticals (KALV) United States $0.684B 0.00
Bioventus (BVS) United States $0.619B 14.98
Relay Therapeutics (RLAY) United States $0.616B 0.00
Organogenesis (ORGO) United States $0.614B 0.00
Elite Pharmaceuticals (ELTP) United States $0.610B 0.00
Tourmaline Bio (TRML) United States $0.604B 0.00
Siga Technologies (SIGA) United States $0.591B 7.30
USANA Health Sciences (USNA) United States $0.587B 12.03
Xencor (XNCR) United States $0.572B 0.00
Savara (SVRA) United States $0.569B 0.00
Oruka Therapeutics (ORKA) United States $0.569B 0.00
Nektar Therapeutics (NKTR) United States $0.557B 0.00
Zevra Therapeutics (ZVRA) United States $0.525B 0.00
Esperion Therapeutics (ESPR) United States $0.440B 0.00
Nanobiotix S.A (NBTX) France $0.431B 0.00
Aquestive Therapeutics (AQST) United States $0.384B 0.00
Aldeyra Therapeutics (ALDX) United States $0.350B 0.00
Altimmune (ALT) United States $0.324B 0.00
Larimar Therapeutics (LRMR) United States $0.323B 0.00
4D Molecular Therapeutics (FDMT) United States $0.302B 0.00
Nature's Sunshine Products (NATR) United States $0.298B 19.40
AleAnna (ANNA) United States $0.283B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.282B 0.00
Lexeo Therapeutics (LXEO) United States $0.262B 0.00
Galectin Therapeutics (GALT) United States $0.255B 0.00
Lyell Immunopharma (LYEL) United States $0.217B 0.00
Heron Therapeutics (HRTX) United States $0.208B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.205B 31.50
Korro Bio (KRRO) United States $0.203B 0.00
OmniAb (OABI) United States $0.198B 0.00
Aclaris Therapeutics (ACRS) United States $0.197B 0.00
MediWound (MDWD) Israel $0.184B 0.00
Journey Medical (DERM) United States $0.182B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
China SXT Pharmaceuticals (SXTC) China $0.172B 0.00
MEI Pharma (MEIP) United States $0.169B 0.00
Achieve Life Sciences (ACHV) Canada $0.152B 0.00
Profound Medical (PROF) Canada $0.136B 0.00
Inhibikase Therapeutics (IKT) United States $0.133B 0.00
Wellgistics Health (WGRX) United States $0.130B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
Avalo Therapeutics (AVTX) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.125B 0.00
Avita Medical (RCEL) United States $0.121B 0.00
Cassava Sciences (SAVA) United States $0.112B 0.00
Dominari Holdings (DOMH) United States $0.100B 0.00
Surrozen (SRZN) United States $0.098B 0.00
Cardiol Therapeutics (CRDL) Canada $0.094B 0.00
Champions Oncology (CSBR) United States $0.091B 20.62
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
Pyxis Oncology (PYXS) United States $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Liminatus Pharma (LIMN) United States $0.079B 0.00
Context Therapeutics (CNTX) United States $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Assertio Holdings (ASRT) United States $0.074B 0.00
Prelude Therapeutics (PRLD) United States $0.072B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Karyopharm Therapeutics (KPTI) United States $0.068B 0.00
Gain Therapeutics (GANX) United States $0.067B 0.00
Inotiv (NOTV) United States $0.060B 0.00
DURECT (DRRX) United States $0.060B 0.00
PolyPid (PYPD) Israel $0.054B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.053B 0.00
Rafael Holdings (RFL) United States $0.053B 0.00
Jupiter Neurosciences (JUNS) United States $0.052B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.91
Fractyl Health (GUTS) United States $0.050B 0.00
Plus Therapeutics (PSTV) United States $0.049B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
Tempest Therapeutics (TPST) United States $0.048B 0.00
Klotho Neurosciences (KLTO) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.043B 0.00
FibroGen (FGEN) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Cosmos Health (COSM) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
Mangoceuticals (MGRX) United States $0.021B 0.00
Incannex Healthcare (IXHL) Australia $0.020B 0.00
Ainos (AIMD) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
BioVie (BIVI) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Aptorum Group (APM) United Kingdom $0.012B 0.00
ESSA Pharma (EPIX) Canada $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
VYNE Therapeutics (VYNE) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Vyome Holdings (HIND) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Aditxt (ADTX) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
CDT Equity (CDT) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
SHINECO (SISI) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.69
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.60
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00